Aptamers Engineered Nanocarriers for Cancer Therapy 2023
DOI: 10.1016/b978-0-323-85881-6.00017-8
|View full text |Cite
|
Sign up to set email alerts
|

Relevance of aptamers as targeting ligands for anticancer therapies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 85 publications
0
1
0
Order By: Relevance
“… 184 Nano-complex designed with AS1411 aptamers, melittin and AuNPs produced significant selective cytotoxicity to MCF-7 BC cells compared to L929 cells ensuring site-directed delivery of melittin. 185 AuNP modified with polyA sequences, AS1411 aptamer and antagomir-155 influences targeted delivery and promotes apoptosis by enhancing the expression of Tp53INP1 in MCF-7 cells. 186 …”
Section: Engineering Aunps With Diverse Moieties For Bc Managementmentioning
confidence: 99%
“… 184 Nano-complex designed with AS1411 aptamers, melittin and AuNPs produced significant selective cytotoxicity to MCF-7 BC cells compared to L929 cells ensuring site-directed delivery of melittin. 185 AuNP modified with polyA sequences, AS1411 aptamer and antagomir-155 influences targeted delivery and promotes apoptosis by enhancing the expression of Tp53INP1 in MCF-7 cells. 186 …”
Section: Engineering Aunps With Diverse Moieties For Bc Managementmentioning
confidence: 99%